Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/05/2014 | CN101704812B Azasugar compounds and preparation method and application thereof |
03/05/2014 | CN101701006B Phenethanolamine derivatives for treatment of respiratory diseases |
03/05/2014 | CN101541769B Polymorphic forms of DEFERASIROX (ICL670A) |
03/05/2014 | CN101530560B External medicament for treating burn and scald |
03/05/2014 | CN101495464B Prokineticin 1 receptor antagonists |
03/05/2014 | CN101415328B Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same |
03/05/2014 | CN101248038B Crystalline solid forms of tigecycline and methods of preparing same |
03/05/2014 | CN101227901B Anti-inflammatory agents |
03/05/2014 | CN101027063B Use of difructose anhydride for preparation drug |
03/04/2014 | US8664440 Method for preparing aliskiren and its intermediates thereof |
03/04/2014 | US8664411 Tetrahydropyranochromene gamma secretase inhibitors |
03/04/2014 | US8664408 Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]proxy}benzamide hydrochloride and pharmaceutical compositions containing it |
03/04/2014 | US8664407 Chemical linkers with single amino acids and conjugates thereof |
03/04/2014 | US8664403 Process |
03/04/2014 | US8664401 N-linked hydroxamic acid derivatives useful as antibacterial agents |
03/04/2014 | US8664395 Purification 4-aza-androst-1-ene-17-oic acid from 4-aza-androstan-17-oic acid |
03/04/2014 | US8664392 Pyrazine derivatives for bioconjugation |
03/04/2014 | US8664390 Process for the introduction of hydroxyethoxy side chain in bosentan |
03/04/2014 | US8664387 Pyridoquinazolinone M1 receptor positive allosteric modulators |
03/04/2014 | US8664382 Antibacterial compositions comprising metal phthalocyanine analogues |
03/04/2014 | US8664372 Process for producing 1,2-trans-glycoside compound |
03/04/2014 | US8664279 Compositions and methods for metabolic imaging |
03/04/2014 | US8664278 Stabilized compositions of volatile alkylating agents and methods of using thereof |
03/04/2014 | US8664276 Stilbene analogs and methods of treating cancer |
03/04/2014 | US8664275 Crystalline form of Bimatoprost, preparation method and use thereof |
03/04/2014 | US8664274 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses |
03/04/2014 | US8664273 Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin |
03/04/2014 | US8664271 Stabilized leukotriene B4 (LTB4) agent pharmaceutical formulation |
03/04/2014 | US8664269 Nitroglycerin therapy for those unable to metabolize nitroglycerin |
03/04/2014 | US8664268 Gallium compositions for the treatment of liver cancer and methods of use |
03/04/2014 | US8664267 Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide) |
03/04/2014 | US8664266 Hepsin inhibitors |
03/04/2014 | US8664265 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
03/04/2014 | US8664263 Stilbene compound, light-emitting element, light-emitting device, electronic device, and lighting device |
03/04/2014 | US8664262 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan |
03/04/2014 | US8664261 Organic compounds having cooling properties |
03/04/2014 | US8664260 De novo synthesis of bacteriochlorins |
03/04/2014 | US8664259 Oil-based suspension concentrates |
03/04/2014 | US8664258 Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
03/04/2014 | US8664256 Kinesin inhibitors as cancer therapeutics |
03/04/2014 | US8664255 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof |
03/04/2014 | US8664254 Dual-acting imidazole antihypertensive agents |
03/04/2014 | US8664253 Imidazole derivatives useful as modulators of FAAH and as FAAH imaging agents |
03/04/2014 | US8664252 Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy |
03/04/2014 | US8664251 Ryanodine receptor inhibitors for treatment of T-cell mediated disorders |
03/04/2014 | US8664249 Tetrasubstituted benzenes |
03/04/2014 | US8664248 Derivatives of pyridoxine for inhibiting HIV integrase |
03/04/2014 | US8664247 Acyclic organonitro compounds for use in treating cancer |
03/04/2014 | US8664246 Substituted pyridines, and use thereof as GSK3 inhibitors |
03/04/2014 | US8664245 Fumarate salts of a histamine H3 receptor antagonist |
03/04/2014 | US8664244 Compounds as c-Met kinase inhibitors |
03/04/2014 | US8664243 Sulfonamide compound and crystal thereof |
03/04/2014 | US8664242 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
03/04/2014 | US8664241 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof |
03/04/2014 | US8664240 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |
03/04/2014 | US8664239 Tacrolimus for improved treatment of transplant patients |
03/04/2014 | US8664238 Indenoisoquinolinone derivatives, manufacturing method and medical use thereof |
03/04/2014 | US8664237 Spiperone derivatives and methods of treating disorders |
03/04/2014 | US8664236 1H-pyrrolo[2,3 b]-pyridine derivatives |
03/04/2014 | US8664235 6-Halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests |
03/04/2014 | US8664233 Substituted 5H-pyrimido[5,4-B]indoles, method for the production thereof and use thereof for treating non-solid malignant tumors of the blood-producing system |
03/04/2014 | US8664231 Concentrated methotrexate solutions |
03/04/2014 | US8664230 Pyridopyrimidine derivatives and use thereof |
03/04/2014 | US8664228 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
03/04/2014 | US8664227 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
03/04/2014 | US8664226 Compound having 3-heteroarylpyrimidin-4-(3H)-one structure and pharmaceutical preparation containing same |
03/04/2014 | US8664225 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
03/04/2014 | US8664224 External preparation for athlete's foot treatment |
03/04/2014 | US8664223 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
03/04/2014 | US8664222 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
03/04/2014 | US8664221 Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent |
03/04/2014 | US8664220 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
03/04/2014 | US8664219 Aminopyrimidines useful as inhibitors of protein kinases |
03/04/2014 | US8664218 Pharmaceutical compounds |
03/04/2014 | US8664216 Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes |
03/04/2014 | US8664215 Ocular allergy treatments with alcaftadine |
03/04/2014 | US8664214 Small molecule potentiators of metabotropic glutamate receptors I |
03/04/2014 | US8664213 Spiro bicyclic diamine derivatives as HIV attachment inhibitors |
03/04/2014 | US8664212 Diazo bicyclic Smac mimetics and the uses thereof |
03/04/2014 | US8664211 Modified amino acid for the inhibition of platelet aggregation |
03/04/2014 | US8664210 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
03/04/2014 | US8664209 Daptomycin for multiple sclerosis |
03/04/2014 | US8664208 Tanaproget compositions containing ethinyl estradiol |
03/04/2014 | US8664207 Organic compounds |
03/04/2014 | US8664206 Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
03/04/2014 | US8664205 Oil-in-water emulsion lotion containing 22-oxa-1α, 25-dihydroxyvitamin D3 and method of treatment of skin disorder using the same |
03/04/2014 | US8664204 Phosphoramidate alkylator prodrugs |
03/04/2014 | US8664203 Thiazole derivatives and their use as P2Y12 receptor antagonists |
03/04/2014 | US8664201 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
03/04/2014 | US8664200 Derivatives of 1-amino-2-cyclobutylethylboronic acid |
03/04/2014 | US8664199 Method and system for reversal of interactions between hydrophobically modified biopolymers and vesicles or cell membranes |
03/04/2014 | US8664197 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
03/04/2014 | US8664196 Shark-like chondroitin sulphate and process for the preparation thereof |
03/04/2014 | US8664195 Phosphorus-containing prodrugs |
03/04/2014 | US8664188 siRNA compositions and methods for potently inhibiting viral infection |
03/04/2014 | US8664187 Methods of treatment of endobronchial infections |
03/04/2014 | US8664186 Stambomycin and derivatives, their production and their uses as drugs |
03/04/2014 | US8664185 Method for preparing polyphenol extracts from spinach leaves |
03/04/2014 | US8664182 Methods of inhibiting cancer cell growth with HDAC inhibitors and methods of screening for HDAC10 inhibitors |
03/04/2014 | US8664181 Dual acting prodrugs |